Recent Updates
Recently added Catalysts
ARGX Positive Sentiment Score: 70/100

argenx to Present at BofA Securities 2026 Health Care Conference

Wednesday, May 6, 2026 1 min read
Key Takeaway: argenx announced that CEO Karen Massey will present at the BofA Securities 2026 Health Care Conference on May 12, 2026. The presentation will focus on the company's advancements in treating severe autoimmune diseases. A live webcast will be available, along with a replay for 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Karen Massey will present at a prominent healthcare conference.
  • The presentation highlights argenx's commitment to autoimmune disease treatment.
  • Live webcasts and replays increase accessibility for investors.

Full Press Release Details

May 6, 2026Amsterdam, the Netherlands– argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, Chief Executive Officer, will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT.
A live webcast of the presentation may be accessed on the Investors section of the argenx website atargenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visitwww.argenx.comand follow us onLinkedIn,Instagram,Facebook, andYouTube.

Contacts

Media:

Ben Petokbpetok@argenx.com

Investors:

Alexandra Royaroy@argenx.com

Frequently Asked Questions

When will argenx present at the BofA Securities conference?

Karen Massey will present on May 12, 2026, at 10:40 a.m. PT.

How can I access the webcast of the presentation?

The live webcast can be accessed on the Investors section of the argenx website.

What is argenx's focus in immunology?

argenx is committed to improving lives affected by severe autoimmune diseases.

Will the presentation be available after the event?

Yes, a replay of the webcast will be available for approximately 30 days.

Tags: ARGX Viatris Investor Conferences Healthcare argenx healthcare conference autoimmune diseases Karen Massey BofA Securities
Last updated: May 6, 2026